A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
Clinical trial NCT05721287 · COMPLETED
Trial details
- NCT number
- NCT05721287
- Sponsor
- Sparian Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2023-08-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.